CaNAL is a longitudinal observational cohort study of patients diagnosed with Primary Biliary Cholangitis (PBC), Autoimmune Hepatitis (AIH), or overlap syndrome. This study creates a nationwide registry and network focusing on high quality long-term follow-up of individual patient data from major Canadian centers. Primary Biliary Cholangitis (PBC) and Autoimmune Hepatitis (AIH) are rare and slowly progressive liver diseases associated with development of cirrhosis, liver cancer (HCC) and liver failure requiring liver transplantation or leading to premature death. The rarity and slowly progressive nature of these autoimmune liver diseases make them difficult to study and only a large scale approach combining patient data from multiple centers across Canada will allow new insights. The primary aim of the Canadian Network for Autoimmune Liver Disease is to build a Canadian registry of patients with PBC, AIH, and overlap syndrome. We capture patient characteristics, laboratory assessments and natural history, patient-reported outcomes including quality of life measures and environmental exposures, response to treatment, and pre- and post-transplant outcomes. We will then identify risk factors associated with critical outcomes for the patient, including response to treatment, progression to transplant, risk of liver cancer, and recurrent disease after transplant. We can identify biomarkers (biochemical indicators of progression of disease) to help diagnose autoimmune liver disease at its earliest stages, ensuring timely treatment and preventing disease progression. CaNAL will provide a better understanding of autoimmune liver diseases, biomarkers predictive of disease progression or non-response to therapy as well as better knowledge of the etiology and pathogenesis. CaNAL will also help to serve as a platform for conducting clinical trials or targeted lab-studies to answer important questions that are unlikely to be evaluated by the pharmaceutical industry.
Study Type
OBSERVATIONAL
Enrollment
2,500
Observational; no intervention
Foothills Medical Centre
Calgary, Alberta, Canada
NOT_YET_RECRUITINGUniversity of Alberta Hospital
Edmonton, Alberta, Canada
RECRUITINGVancouver General Hospital
Vancouver, British Columbia, Canada
NOT_YET_RECRUITINGSt. Paul's Hospital
Vancouver, British Columbia, Canada
NOT_YET_RECRUITINGHealth Sciences Centre
Winnipeg, Manitoba, Canada
NOT_YET_RECRUITINGQueen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
ACTIVE_NOT_RECRUITINGMcMaster University Medical Centre
Hamilton, Ontario, Canada
NOT_YET_RECRUITINGKingston Health Sciences Centre (HDH Site)
Kingston, Ontario, Canada
ACTIVE_NOT_RECRUITINGLondon Health Sciences Centre - University Hospital
London, Ontario, Canada
RECRUITINGThe Ottawa Hospital
Ottawa, Ontario, Canada
RECRUITING...and 5 more locations
Liver transplant-free survival over time
Time-to-event
Time frame: Up to 6 years or time of death/liver transplant
Biochemical values over time (e.g. aspartate aminotransferase, alkaline phosphatase, alanine aminotransferase, Bilirubin)
Investigate trends of different biochemical values over time
Time frame: Through study completion, an average of 6 months
Short Form 36 (SF-36)
Health-Related Quality of Life
Time frame: Through study completion, an average of 6 months
PBC-40
Health-Related Quality of Life, specific to Primary Biliary Cholangitis
Time frame: Through study completion, an average of 6 months
5D Pruritus Scale
Itch-Related Quality of Life through 5 dimensions: duration, degree, direction, disability, and distribution. Each dimension is scored from 1(lowest) to 5(highest) for a total score range of 5-25
Time frame: Through study completion, an average of 6 months
Itch Visual Analog Scale
Itch-Related Quality of Life; Continuous unitless itch scale from no itch to worst itch imaginable
Time frame: Through study completion, an average of 6 months
Itch Numeric Rating Scale
Itch-Related Quality of Life; Categorical integer scale from 0 (no itch) to 10 (worst itch imaginable)
Time frame: Through study completion, an average of 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.